IFNB1 and neoplasm: We previously reported that IFN-β enhances the anti-melanoma effects of anti-PD-1 Abs in mouse B16F10 melanoma by recruiting effector cells, instead of regulatory T cells (Tregs), to tumor sites in vivo [10].